NCBA’s webinar legal educational program consists of high-quality legal education presented by expert attorneys at the top of their field in online webinars. The content for our programs is wide-ranging, relevant, and addresses everything from the foundation of the cannabis movement to the most topical issues affecting stakeholders in the industry. Our goal is to provide information the cannabis bar needs to become fluent in the issues that affect our cannabis industry clients.
2018 Webinar Series
The Series will cover a range of topics that support the practice of law for business attorneys serving the cannabis industry. Webinars will generally take place on the fourth Thursday of each month at noon Eastern (9am Pacific), unless otherwise noted.
CLE credit will be provided in California, Colorado, New York, and select other states based on attendee registration and NCBA policy. NCBA will offer support for attorneys seeking to obtain individual credit in additional states.
Annual members receive a 50% discount and sustaining members receive free access to the 2018 webinar series.
January 25, 9am Pacific (Noon Eastern)
Let’s Make a Federal Case of It (HIA v. DEA)
Presented by Bob Hoban (Hoban Law Group)
Our first webinar will address the pending litigation in Hemp Industries Association v. Drug Enforcement Agency, presented by Bob Hoban, Managing Partner of Hoban Law Group and lead counsel on the case (HIA v. DEA). Register Here.
In December 2016, the DEA published a ‘Final Rule’ that classifies cannabis-derived extracts, such as CBD oil, in their own category with a code number to “better track these materials and comply with treaty provisions.” The announcement by the DEA ultimately serves to make any cannabis extract a Schedule 1 narcotic.
In January 2017, the Hoban Law Group filed a petition on behalf of three clients against the DEA in the U.S. Court of Appeals for the Ninth District. The clients represented by Hoban Law Group in the suit are Hemp Industries Association, RMH Holdings, LLC and Centuria Natural Foods, Inc. The companies are based in California, Colorado and Nevada respectively and are all active in the legal hemp trade. Arguments before the 9th Circuit are scheduled for February 15, 2018.
State and Federal Legalization: What’s Next
Presented by Karen O'Keefe (MPP Director of State Policies) and Michael Correia (NCIA Director of Government Relations)
Representatives for leading advocacy organizations, Marijuana Policy Project (MPP) and the National Cannabis Industry Association (NCIA), present on legalization successes and pending initiatives. Karen O’Keefe, MPP Director of State Policies, will look back at recent successful state legalization efforts, and then focus on the 2018 outlook for state ballot initiatives and legislative efforts across the country. Michael Correia, NCIA Director of Government Relations, will present on federal priorities in the U.S. Senate and House, including a discussion of specific pending legslation.
Registration will open soon!
March 22, 9am Pacific (Noon Eastern)
Let’s Make A Federal Case Of It: Washington v. Sessions
Presented by Michael Hiller and Lauren Rudick
Hear about the pending case: Washington v. Sessions. In July 2017, Hiller PC filed a lawsuit challenging the constitutionality of the Controlled Substances Act as to classifying Cannabis as a “Schedule I drug,” as such classification is so irrational that it violates the U.S. Constitution. In their Complaint, plaintiffs demonstrate that the Federal Government does not, and could not possibly, believe that Cannabis meets the definition of a Schedule I drug, which is reserved for the most dangerous of substances, such as heroin, LSD and mescaline. By way of comparison, cocaine and crystal meth are considered Schedule II drugs and are thus considered less addictive and less dangerous.
The plaintiffs include:
- Retired professional football player (and Super Bowl Champion) Marvin Washington, who desires, but is ineligible (due to the CSA) to obtain grants under the Federal Minority Business Enterprise program to open a business that would allow professional football players (among others) to treat with medical Cannabis to reduce opioid dependency and addition.
- 11-year old Alexis Bortell, who moved to Colorado from Texas so that she could treat her intractable epilepsy with medical Cannabis.
- Six-year old Jagger Cotte, who suffers from Leigh’s Disease and who uses medical Cannabis to control otherwise excruciating pain and to lengthen his life.
- Disabled military combat veteran Jose Belen, who uses medical Cannabis to control his post-traumatic stress disorder (PTSD).
- The Cannabis Cultural Association, whose membership includes many people of color that contend the CSA was enacted, and has been enforced, in a discriminatory manner.
Registration will open soon!
Check back soon for more information on additional upcoming webinars!